339 related articles for article (PubMed ID: 10088816)
1. Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation.
Webster AR; Maher ER; Moore AT
Arch Ophthalmol; 1999 Mar; 117(3):371-8. PubMed ID: 10088816
[TBL] [Abstract][Full Text] [Related]
2. Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study.
Dollfus H; Massin P; Taupin P; Nemeth C; Amara S; Giraud S; Béroud C; Dureau P; Gaudric A; Landais P; Richard S
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3067-74. PubMed ID: 12202531
[TBL] [Abstract][Full Text] [Related]
3. Genotype-phenotype correlation in von Hippel-Lindau disease with retinal angiomatosis.
Wong WT; Agrón E; Coleman HR; Reed GF; Csaky K; Peterson J; Glenn G; Linehan WM; Albert P; Chew EY
Arch Ophthalmol; 2007 Feb; 125(2):239-45. PubMed ID: 17296901
[TBL] [Abstract][Full Text] [Related]
4. A clinical and molecular genetic analysis of solitary ocular angioma.
Webster AR; Maher ER; Bird AC; Gregor ZJ; Moore AT
Ophthalmology; 1999 Mar; 106(3):623-9. PubMed ID: 10080225
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization and ophthalmic investigation of a large family with type 2A Von Hippel-Lindau Disease.
Allen RC; Webster AR; Sui R; Brown J; Taylor CM; Stone EM
Arch Ophthalmol; 2001 Nov; 119(11):1659-65. PubMed ID: 11709017
[TBL] [Abstract][Full Text] [Related]
6. Genotype-phenotype correlation in ocular von Hippel-Lindau (VHL) disease: the effect of missense mutation position on ocular VHL phenotype.
Mettu P; Agrón E; Samtani S; Chew EY; Wong WT
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4464-70. PubMed ID: 20375333
[TBL] [Abstract][Full Text] [Related]
7. Genotype-phenotype correlation in von Hippel-Lindau disease.
Reich M; Jaegle S; Neumann-Haefelin E; Klingler JH; Evers C; Daniel M; Bucher F; Ludwig F; Nuessle S; Kopp J; Boehringer D; Reinhard T; Lagrèze WA; Lange C; Agostini H; Lang SJ
Acta Ophthalmol; 2021 Dec; 99(8):e1492-e1500. PubMed ID: 33720516
[TBL] [Abstract][Full Text] [Related]
8. Ocular manifestations of von Hippel-Lindau disease: clinical and genetic investigations.
Chew EY
Trans Am Ophthalmol Soc; 2005; 103():495-511. PubMed ID: 17057815
[TBL] [Abstract][Full Text] [Related]
9. Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma.
Lee JS; Lee JH; Lee KE; Kim JH; Hong JM; Ra EK; Seo SH; Lee SJ; Kim MJ; Park SS; Seong MW
BMC Med Genet; 2016 Jul; 17(1):48. PubMed ID: 27439424
[TBL] [Abstract][Full Text] [Related]
10. Clinical characterization of retinal capillary hemangioblastomas in a large population of patients with von Hippel-Lindau disease.
Wong WT; Agrón E; Coleman HR; Tran T; Reed GF; Csaky K; Chew EY
Ophthalmology; 2008 Jan; 115(1):181-8. PubMed ID: 17543389
[TBL] [Abstract][Full Text] [Related]
11. Retinal angiomatosis in von Hippel-Lindau disease: a longitudinal ophthalmologic study.
Kreusel KM; Bechrakis NE; Krause L; Neumann HP; Foerster MH
Ophthalmology; 2006 Aug; 113(8):1418-24. PubMed ID: 16769118
[TBL] [Abstract][Full Text] [Related]
12. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.
Gläsker S; Bender BU; Apel TW; Natt E; van Velthoven V; Scheremet R; Zentner J; Neumann HP
J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):758-62. PubMed ID: 10567493
[TBL] [Abstract][Full Text] [Related]
13. VHL Germline Mutations in Argentinian Patients with Clinical Diagnoses or Single Typical Manifestations of Type 1 von Hippel-Lindau Disease.
Mathó C; Sansó G; Diez B; Barontini M; Pennisi PA
Genet Test Mol Biomarkers; 2016 Dec; 20(12):771-776. PubMed ID: 27617348
[TBL] [Abstract][Full Text] [Related]
14. Retinal hemangioblastoma: prevalence, incidence and frequency of underlying von Hippel-Lindau disease.
Binderup MLM; Stendell AS; Galanakis M; Møller HU; Kiilgaard JF; Bisgaard ML
Br J Ophthalmol; 2018 Jul; 102(7):942-947. PubMed ID: 28972023
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal analysis of retinal hemangioblastomatosis and visual function in ocular von Hippel-Lindau disease.
Toy BC; Agrón E; Nigam D; Chew EY; Wong WT
Ophthalmology; 2012 Dec; 119(12):2622-30. PubMed ID: 22906772
[TBL] [Abstract][Full Text] [Related]
16. Retinal angiomatosis and von Hippel-Lindau disease.
Kreusel KM; Bechrakis NE; Heinichen T; Neumann L; Neumann HP; Foerster MH
Graefes Arch Clin Exp Ophthalmol; 2000 Nov; 238(11):916-21. PubMed ID: 11148816
[TBL] [Abstract][Full Text] [Related]
17. Von Hippel-Lindau disease germline mutations in Mexican patients with cerebellar hemangioblastoma.
Rasmussen A; Nava-Salazar S; Yescas P; Alonso E; Revuelta R; Ortiz I; Canizales-Quinteros S; Tusié-Luna MT; López-López M
J Neurosurg; 2006 Mar; 104(3):389-94. PubMed ID: 16572651
[TBL] [Abstract][Full Text] [Related]
18. Genotype-phenotype correlations, and retinal function and structure in von Hippel-Lindau disease.
Wittström E; Nordling M; Andréasson S
Ophthalmic Genet; 2014 Jun; 35(2):91-106. PubMed ID: 24555745
[TBL] [Abstract][Full Text] [Related]
19. Hemangioblastomas of the retina: impact of von Hippel-Lindau disease.
Niemelä M; Lemeta S; Sainio M; Rauma S; Pukkala E; Kere J; Böhling T; Laatikainen L; Jääskeläinen J; Summanen P
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1909-15. PubMed ID: 10845616
[TBL] [Abstract][Full Text] [Related]
20. Case report: a synonymous VHL mutation (c.414A > G, p.Pro138Pro) causes pathogenic familial hemangioblastoma through dysregulated splicing.
Liu F; Calhoun B; Alam MS; Sun M; Wang X; Zhang C; Haldar K; Lu X
BMC Med Genet; 2020 Feb; 21(1):42. PubMed ID: 32106822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
